Status:
COMPLETED
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Efficacy and Safety of Bromfenac Ophthalmic Solution in Cataract Surgery
Eligibility Criteria
Inclusion
- Scheduled for cataract surgery
Exclusion
- Known hypersensitivity to bromfenac and salicylates
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT00704418
Start Date
June 1 2008
End Date
December 1 2009
Last Update
January 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618